Now accepting early access partners

Validation that moves
at the speed of science.

EVOLV | The Validation Factory

The first AI-native Computer System Validation platform built for GAMP 5, 21 CFR Part 11, and FDA QMSR. Generate compliant URS, automate risk assessment, and govern AI model changes — in minutes, not months.

Request Early Access ▶ Try Live Demo
GAMP 5 21 CFR Part 11 21 CFR Part 820 QMSR ISO 13485:2016 FDA PCCP Guidance Aug 2025 GMP Annex 11 EU GMP

The Problem

CSV validation still runs on
spreadsheets and email chains.

Life sciences teams spend months on documentation that should take days. Regulatory guidance has changed. Most platforms haven't.

📋

Weeks to generate a URS

Requirements written manually in Word, reviewed in meetings, rewritten after audit findings. No regulatory traceability. No version control. Just documents.

⚠️

Regulations change. VMPs don't.

FDA's QMSR replaced the QSR on February 2, 2026. The PCCP final guidance landed August 2025. Most validation plans still cite rules that no longer exist.

🤖

AI in GxP with no governance

Drug interaction predictors and defect classifiers are being deployed with no PCCP, no change control, no audit trail. FDA inspectors are starting to notice.

The Platform

One platform.
The entire validation lifecycle.

From first requirement to post-market governance — every step compliant, auditable, and powered by AI that knows GAMP 5.

📄

Validation Factory

Generate GAMP 5-compliant URS from plain English. SMART refinement, PCCP verification, UR/FR decomposition, CSA test scripts, and PDF export with e-signature — in one guided workflow. What took days takes minutes.

URS Generation SMART Refinement UR/FR Decomposition CSA Test Scripts PDF + E-Signature
🔄

Change Control

ServiceNow change requests cross-referenced against your system portfolio in real time. GxP classification, GAMP-aware risk calculation using Severity × Occurrence × Detectability, and automatic revalidation flags. No spreadsheet required.

ServiceNow Integration GxP Classification GAMP Risk Matrix Revalidation Flags
🤖

AI Model Governance

Validated AI models treated as GAMP Category 5 assets. PCCP-aware change assessment aligned to FDA final guidance August 2025. Human-in-the-loop approval queue with 21 CFR Part 11 compliant audit trail.

PCCP Assessment HITL Governance FDA Aug 2025 21 CFR Part 11
📊

Portfolio Dashboard

Every system, every site, every phase — one view. RAG status, action items, regulatory due dates. Register new systems with GxP classification and track their full validation journey from plan to monitor. Built for QA Heads and CTOs.

RAG Status System Registry Lifecycle Tracking Multi-Site

See It In Action

Watch EVOLV handle in 4 minutes
what takes your team weeks.

Three real workflows. No voiceover scripts. No slides. Just the platform doing what it's built to do.

Demo 01

Portfolio Dashboard

Your entire validated system landscape — GAMP category, GxP status, risk level, revalidation due dates — in one view. Built for QA Heads and CTOs who need portfolio-wide compliance visibility instantly..

Demo 02

Change Control & GxP Classification

ServiceNow CR received → portfolio cross-reference → GAMP risk calculation → revalidation decision. Automatic.

Demo 03

AI Model Governance

AI model change in a validated system → PCCP assessment → Governance Hub → human-in-the-loop approval → 21 CFR Part 11 audit trail. Built for FDA's final guidance (Aug 2025).

Try the Validation Factory — live, right now.

Generate a real GAMP 5-compliant URS from your own requirement. No login required.

▶ Open Live Demo

Built For

EVOLV speaks the language
of regulated industries.

Whether you're defending a validation package in an inspection or governing 150 systems across 25 sites — EVOLV gives you the records to back it up.

🧪 QA Head · CSV Manager

Stop writing in Word. Start validating.

EVOLV generates, verifies, and manages your entire validation portfolio with a complete audit trail FDA inspectors can review on the spot.

  • URS from plain English in minutes
  • SMART requirements, auto-verified against GAMP 5
  • Full lifecycle tracking — Plan to Monitor
  • Audit-ready PDFs with e-signature

📋 VP Regulatory Affairs

FDA updated the rules. EVOLV already knows.

QMSR is mandatory. PCCP guidance is final. EVOLV cites the right regulations, routes the right changes, and produces the records you need when an inspector walks in.

  • Aligned to FDA PCCP Guidance Aug 18, 2025
  • 21 CFR Part 820 QMSR / ISO 13485:2016
  • SHA-256 tamper-evident audit trail
  • 21 CFR Part 11 electronic records

💻 CTO · CDO

Your AI models are GAMP Cat 5 assets.

EVOLV gives you the governance infrastructure to deploy AI in GxP contexts without regulatory exposure — with a full HITL approval layer and immutable decision records.

  • AI model registry with version history
  • PCCP-aware change assessment
  • Human-in-the-loop governance hub
  • Portfolio-wide RAG visibility

Regulatory Coverage

GAMP 5 (2nd Edition) 21 CFR Part 11 21 CFR Part 820 QMSR ISO 13485:2016 FDA PCCP Guidance Aug 18, 2025 GMP Annex 11 EU GMP GLP ISO 17025 GDPR 21 CFR Part 820.35 QMSR FDA CSA Guidance 2022

Early Access

Join our first cohort of life sciences partners.

We're working with a small group of pharma and biotech companies before general availability. Early access partners get priority onboarding, direct access to the founding team, and founding-tier pricing locked in permanently.

🔒  We'll respond within 1 business day. Your information is never shared.

How to Choose the Right Life Sciences Consulting Firm: A Buyer’s Guide

Feb 28, 2026

Choosing the right life sciences consulting firm is a critical decision for any organization in the healthcare, pharmaceutical, or biotechnology industries. The right partner can provide invaluable expertise, streamline processes, and drive innovation. However, with so many options available, finding the perfect fit can be challenging.

life sciences consulting

Identify Your Needs

The first step in selecting a consulting firm is to clearly define your organization's specific needs and objectives. Determine whether you require assistance with regulatory compliance, clinical trials, market access, or another area. Understanding your priorities will help you narrow down the list of potential firms.

Consider creating a detailed list of the services you require and any specific outcomes you wish to achieve. This will serve as a guide during your search and help you communicate more effectively with prospective partners.

Evaluate Expertise and Experience

When evaluating potential consulting firms, it's crucial to assess their expertise and experience in the life sciences sector. Look for firms with a proven track record of success in your specific area of need. Review case studies, client testimonials, and industry awards to gauge their level of competence.

consulting meeting

Additionally, consider the qualifications and backgrounds of the firm’s consultants. A team with diverse experience and specialized knowledge can offer more nuanced insights and innovative solutions.

Consider Reputation and References

A firm's reputation within the industry is often a reliable indicator of its capabilities. Seek recommendations from peers, industry groups, or online reviews. A firm with a strong, positive reputation is likely to deliver high-quality services.

Request references from the consulting firm and reach out to their previous clients to gather firsthand accounts of their experiences. This can provide valuable insights into the firm's reliability, communication style, and overall effectiveness.

team collaboration

Assess Communication and Collaboration

Effective communication and collaboration are essential for a successful partnership. During initial consultations, pay attention to how well the firm listens to your needs and how clearly they communicate their strategies. A good consulting firm should be able to explain complex concepts in an understandable manner.

Evaluate the firm's willingness to work closely with your team. A collaborative approach ensures that the solutions provided are tailored to your organization’s unique challenges and goals.

Analyze Cost and Value

While cost is an important consideration, it should not be the sole determining factor. Instead, focus on the value that the consulting firm can bring to your organization. Compare pricing structures and ensure there are no hidden fees. A transparent, flexible pricing model is often a sign of a trustworthy partner.

Consider the potential return on investment. A more expensive firm with a strong track record of delivering results can ultimately be more cost-effective than a cheaper alternative with limited capabilities.

Make an Informed Decision

After thoroughly evaluating your options, it's time to make an informed decision. Trust your instincts and choose a firm that aligns with your organizational culture and values. The right life sciences consulting partner will empower your organization to achieve its goals and drive long-term success.

Remember, selecting the right consulting firm is an investment in your organization’s future. By following these guidelines, you can make a choice that positions your organization for growth and innovation in the dynamic life sciences industry.